Quantamental Technologies LLC Glycomimetics Inc Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$4.03 - $6.5 $8,285 - $13,364	-2,056 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$2.8 - $12.85 $3,516 - $16,139	1,256 Added 157.0%	2,056 $9,000
Q2 2019 Aug 12, 2019	BUY	$10.6 - $13.12 $4,240 - $5,248	400 Added 100.0%	800 $10,000
Q1 2019 Apr 29, 2019	BUY	$9.96 - $13.44 $3,984 - $5,376	400 New	400 $5,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.